Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross-sectional, Retrospective Screening and Case-control Study Examining the Frequency of, and Risk Factors Associated With, Impulse Control Disorders in Parkinson's Disease Patients Treated With MIRAPEX® (Pramipexole) and Other Anti-parkinson Agents (DOMINION Study)

NCT00617019 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00617019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00617019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross-sectional, Retrospective Screening and Case-control Study Examining the Frequency of, and Risk Factors Associated With, Impulse Control Disorders in Parkinson's Disease Patients Treated With MIRAPEX® (Pramipexole) and Other Anti-parkinson Agents (DOMINION Study)
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
September 30, 2006
Completion date
Not reported
Enrollment
3,234 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease